Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

被引：0
|
作者：
Min Chong Kim
Jung Eun Choi
Soo Jung Lee
Young Kyung Bae
机构：
[1] Yeungnam University College of Medicine,Department of Pathology
[2] Yeungnam University College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Breast Cancer; Overall Survival; TP53 Mutation; Hormone Receptor Status; Sporadic Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3524 / 3530
页数：6
相关论文
共 50 条
  • [21] Roles of p53 and p16 in triple-negative breast cancer
    Dang, Daniel
    Peng, Yan
    BREAST CANCER MANAGEMENT, 2013, 2 (06) : 537 - 544
  • [22] The BRCA1 promoter methylation is one of the mechanisms of th BRCA1 dysfunction of triple-negative breast cancer
    Yamashita, N.
    Tokunaga, E.
    Tanaka, K.
    Saeki, H.
    Oki, E.
    Kitao, H.
    Morita, M.
    Maehara, Y.
    CANCER RESEARCH, 2013, 73
  • [23] BRCA1 methylation contributes to the triple-negative breast cancer phenotype.
    Nwachukwu, C.
    Grushko, T. A.
    Xu, J.
    Khramtsov, A.
    Olopade, O., I
    CANCER RESEARCH, 2009, 69 (02) : 266S - 266S
  • [24] Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
    Nakamura, Kivvi Duarte
    Ferreira, Elisa
    Ramalho, Rodrigo
    Brianese, Rafael
    Carraro, Dirce
    CANCER RESEARCH, 2017, 77
  • [25] Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer
    Maksimenko, Jelena
    Irmejs, Arvids
    Nakazawa-Miklasevica, Miki
    Melbarde-Gorkusa, Inga
    Trofimovics, Genadijs
    Gardovskis, Janis
    Miklasevics, Edvins
    ONCOLOGY LETTERS, 2014, 7 (01) : 278 - 284
  • [26] BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.
    Rodriguez, A. A.
    Makris, A.
    Harrison, M. K.
    Ostler, P. J.
    Froehlich, A.
    Pavlick, A.
    Wong, H.
    Tsimelzon, A.
    Sexton, K.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Rimawi, M.
    Osborne, C. K.
    Chang, J. C.
    CANCER RESEARCH, 2009, 69 (02) : 358S - 358S
  • [27] miR-199a-3p induces BRCA1 dysfunction in triple-negative breast cancer
    Ho, John C.
    Shin, Vivian Y.
    Chen, Jiawei
    Siu, Man T.
    Cheuk, Isabella
    Kwong, Ava
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [28] Loss of LOC285194 is associated with poor prognosis in triple-negative breast cancer
    Ni, X.
    Shao, Z.
    BREAST, 2015, 24 : S30 - S31
  • [29] Generation of a transcriptome of oncogenic mutant p53 in triple-negative breast cancer
    Steele, Rebecca E.
    McDade, Simon S.
    Mullan, Paul B.
    CANCER RESEARCH, 2017, 77
  • [30] Mutant p53 as a Therapeutic Target for the Treatment of Triple-Negative Breast Cancer
    Synnott, N.
    Crown, J.
    Duffy, M. J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E41 - E41
12345